J Clin Gastroenterol July 2009 PMID 19384249

International survey of patients with IBS: symptom features and their severity, health status, treatments, and risk taking to achieve clinical benefit.

Douglas A Drossman, Carolyn Blank Morris, Susan Schneck, Yuming J B Hu, Nancy J Norton, William F Norton, Stephan R Weinland, Christine Dalton, Jane Leserman, Shrikant I Bangdiwala

Download social card

Mentions

Peak: 1 in Apr 2023

across 4 sources since Apr 2023

Extended reach

2,006

potential audience

Total likes

Video views

1,991

Mentions per month

Apr 2023 – Oct 2024

Where it's discussed

News71 articles
Blogs3 articles
YouTube2 videos
X / Twitter1 posts

AI synopsis

What people are saying

The overall tone indicates strong interest and agreement, highlighted by comments emphasizing the significance of understanding patient perspectives and the risks they are willing to accept, such as 'Patients are willing to endure significant risks' and calls for better treatment options. The words and tone reflect a concern for patient quality of life and a desire to advance therapeutic strategies.

AgreementModerate agreement

Most discussions acknowledge the importance of the study in highlighting patient experiences and treatment challenges, showing general agreement with its findings.

InterestHigh interest

The discussions reveal high interest, with participants eager to explore the nuances of symptom severity and treatment risks.

EngagementModerate engagement

Comments reflect active engagement through sharing personal experiences and debating treatment approaches, though not deeply technical.

ImpactModerate impact

The discussions could influence care approaches and awareness, but primarily serve to inform rather than directly change policies.

Abstract in brief

The survey of almost 2,000 IBS patients revealed that many experience significant impairments in quality of life, including pain, mood disturbances, and dietary restrictions, and are willing to take significant risks or give up years of life for effective symptom relief.
Patients' treatment choices are influenced not only by symptom type but also by perceived severity and the risks they are willing to accept, with many currently using pain medications, including narcotics, and alternative therapies.
There is a strong need for new, effective treatments for IBS, as patients are willing to endure considerable risks to achieve symptom relief, highlighting the importance of understanding patient preferences and improving treatment options.]

Read the full abstract

All mentions

Understanding Reizdarm Without Response to Conventional Treatments

Since my early days as a health journalist and founding my practice, I have encountered many patients with IBS who do not respond to standard therapies, despite similar biomarker profiles. This highlights the complexity…

Thomas Struppe · Oct 22, 2024 1,437 views

Doctor's Perspective on Irritable Bowel Syndrome Insights and Patient Experiences

Many IBS patients feel misunderstood by physicians and see little progress with standard treatments. Research highlights the 'doctor's odyssey' and the need for better understanding and empathy in patient care.

Thomas Struppe · Nov 30, 2023 554 views

R.KSingh

@RKSingh18587012 · X

International survey of patients with IBS: symptom features and their severity, health status, treatments, and risk… https://t.co/q0BcI5XmQv

Apr 25, 2023 · 16 followers View post →